Alicia Finley

Alicia Finley, a healthcare journalist known for her insights on drug pricing and policy, dives deep into the Trump administration's new initiative, ‘TrumpRx.’ She discusses the potential implications of selling discounted drugs directly to consumers and questions whether it's driven by genuine need or political theatrics. The conversation also touches on Pfizer's agreement to bring manufacturing back to the U.S. in exchange for tariff relief and the broader issues of drug pricing, competition with generics, and the risks of government involvement in the market.

Alicia Finley, a public-health columnist at The Wall Street Journal, and Kate Batchelder-Odell from the editorial board dive into the controversy surrounding Tylenol use during pregnancy and its alleged link to autism. They analyze claims made by Donald Trump and RFK Jr., questioning the validity of the research supporting those assertions. The discussion also includes the implications of alarmist messaging on public trust and maternal health, as well as scrutiny of FDA decisions regarding melanoma treatments.